| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/00207451003695690 |
| P8608 | Fatcat ID | release_wwmughpoinerxky24ryxwckaou |
| P698 | PubMed publication ID | 20374079 |
| P5875 | ResearchGate publication ID | 43072082 |
| P2093 | author name string | Majid Ghaffarpour | |
| Mojdeh Ghabaee | |||
| Farzad Asadi | |||
| Behnam Jabedari | |||
| Naser Al-E-Eshagh | |||
| P2860 | cites work | Assessment of current diagnostic criteria for Guillain-Barré syndrome | Q22252936 |
| Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis | Q22252943 | ||
| Method for the measurement of antioxidant activity in human fluids | Q28363970 | ||
| Can malondialdehyde be used as a biological marker of progression in neurodegenerative disease? | Q34609969 | ||
| Multiple sclerosis--the plaque and its pathogenesis | Q36410882 | ||
| Antioxidants and neuroprotection in the adult and developing central nervous system | Q37347234 | ||
| Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis. | Q44469782 | ||
| Vitamins C and E: acute interactive effects on biomarkers of antioxidant defence and oxidative stress. | Q44957882 | ||
| Free radical toxicity and antioxidants in Guillain-Barre syndrome, a preliminary study | Q44980630 | ||
| Cerebrospinal fluid isoprostanes are not related to inflammatory activity in relapsing-remitting multiple sclerosis | Q45080013 | ||
| P433 | issue | 4 | |
| P921 | main subject | Guillain–Barré syndrome | Q205214 |
| multiple sclerosis | Q8277 | ||
| cerebrospinal fluid | Q54196 | ||
| P304 | page(s) | 301-304 | |
| P577 | publication date | 2010-04-01 | |
| P1433 | published in | International Journal of Neuroscience | Q6051511 |
| P1476 | title | Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in Guillain-Barre syndrome and multiple sclerosis patients | |
| P478 | volume | 120 |
| Q42214346 | Anticonvulsant and Neuroprotective Activities of Phragmanthera austroarabica Extract in Pentylenetetrazole-Kindled Mice. |
| Q38896543 | Application of nanomedicine for crossing the blood-brain barrier: Theranostic opportunities in multiple sclerosis. |
| Q37548170 | Assessment of Serum Nitrogen Species and Inflammatory Parameters in Relapsing-Remitting Multiple Sclerosis Patients Treated with Different Therapeutic Approaches |
| Q47768496 | Effect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosis |
| Q36283207 | Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis |
| Q94586330 | Immunomodulatory and anti-oxidative effect of the direct TRPV1 receptor agonist capsaicin on Schwann cells |
| Q39013853 | Improved neuroprotective effects by combining Bacopa monnieri and Rosmarinus officinalis supercritical CO2 extracts |
| Q33597384 | Low serum levels of uric acid and albumin in patients with Guillain-Barre syndrome |
| Q44912998 | Modulation of oxidative stress, apoptosis, and calcium entry in leukocytes of patients with multiple sclerosis by Hypericum perforatum |
| Q27023735 | Multiple sclerosis: molecular mechanisms and therapeutic opportunities |
| Q33617100 | NQO1 gene rs1800566 variant is not associated with risk for multiple sclerosis |
| Q37808095 | Nutraceutical antioxidants as novel neuroprotective agents |
| Q64251070 | Oxidative Stress Related to Iron Metabolism in Relapsing Remitting Multiple Sclerosis Patients With Low Disability |
| Q37699846 | Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment |
| Q38841957 | Oxidative stress-related biomarkers in multiple sclerosis: a review |
| Q36460613 | Redox processes in neurodegenerative disease involving reactive oxygen species |
| Q88983835 | Salivary biomarkers for the diagnosis and monitoring of neurological diseases |
| Q48007847 | Thyroid hormone level is associated with the frequency and severity of Guillain-Barré syndrome |
Search more.